HIV-1C proviral DNA for detection of drug resistance mutations.
BACKGROUND:Using HIV proviral DNA as a template may be suitable for initial detection of transmitted drug resistance mutations (TDRMs) as it is easy to handle and less expensive compared to RNA. However, existing literatures which are mainly focused on HIV-1B subtypes DNA extracted from PBMCs reveal...
Main Authors: | Kahsay Huruy, Andargachew Mulu, Uwe Gerd Liebert, Melanie Maier |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6171930?pdf=render |
Similar Items
-
Correction: HIV-1C proviral DNA for detection of drug resistance mutations.
by: Kahsay Huruy, et al.
Published: (2018-01-01) -
Upward trends of acquired drug resistances in Ethiopian HIV-1C isolates: A decade longitudinal study.
by: Andargachew Mulu, et al.
Published: (2017-01-01) -
Low Incidence of HIV-1C Acquired Drug Resistance 10 Years after Roll-Out of Antiretroviral Therapy in Ethiopia: A Prospective Cohort Study.
by: Andargachew Mulu, et al.
Published: (2015-01-01) -
HIV drug resistance mutations in proviral DNA from a community treatment program.
by: Anne Derache, et al.
Published: (2015-01-01) -
Immune restoration disease and changes in CD4+ T-cell count in HIV- infected patients during highly active antiretroviral therapy at Zewditu memorial hospital, Addis Ababa, Ethiopia
by: Kassu Afework, et al.
Published: (2010-12-01)